Notre Dame Research Shows Promising Results for Improving Pancreatic Cancer Treatment
Intezyne Technologies Granted Orphan Drug Designation for IT-139 in Pancreatic Cancer
Notre Dame Researcher’s Discovery Could Change the Way We Treat Pancreatic Cancer
New Discovery Paves the Way for Pancreatic Cancer Treatment
Notre Dame Researcher: Cancer research a ‘moral obligation’
Mouse Models Advancing Cancer Research
Hill Promotes Cancer Research in Washington
Breakthroughs in Pancreatic Cancer Research Discussed at Recent Symposium
Potential Biomarker Proves Promising for Pancreatic Cancer Diagnostics